Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

NCT02889796 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1759

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Filgotinib
DRUG: Placebo to match filgotinib
DRUG: Adalimumab
DRUG: Placebo to match adalimumab
DRUG: MTX

Sponsor

Gilead Sciences

Collaborators

[object Object]